scispace - formally typeset
N

Nancy A. Jenkins

Researcher at Houston Methodist Hospital

Publications -  743
Citations -  105243

Nancy A. Jenkins is an academic researcher from Houston Methodist Hospital. The author has contributed to research in topics: Gene & Gene mapping. The author has an hindex of 155, co-authored 741 publications receiving 101587 citations. Previous affiliations of Nancy A. Jenkins include Institute of Molecular and Cell Biology & University of Texas MD Anderson Cancer Center.

Papers
More filters
Journal ArticleDOI

Identification and applications of repetitive probes for gene mapping in the mouse.

TL;DR: Three repetitive probes that collectively identify 28 loci dispersed on 16 of the 19 mouse autosomes and the X chromosome establish a skeleton linkage map that can be used to detect linkage over much of the mouse genome.
Journal ArticleDOI

Mammalian antioxidant protein complements alkylhydroperoxide reductase (ahpC) mutation in Escherichia coli.

TL;DR: It is found that the Aop1 gene shows significant nucleotide sequence similarity to the gene coding for the C22 subunit of Salmonella typhimurium alkylhydroperoxide reductase, suggesting it functions as an antioxidant protein.
Journal ArticleDOI

Cloning, expression, and chromosomal localization of the mouse meprin beta subunit.

TL;DR: The cloning and sequencing of the mouse kidney beta subunit and northern blot analysis indicate that alpha and beta probably derived from a common ancestral gene, but have evolved so that their genes are on two different chromosomes, and their tissue-specific expression and post-translational processing differ.
Journal ArticleDOI

Cloning and Characterization of a New Type of Mouse Chemokine

TL;DR: The striking identity of an amino acid stretch encompassing a putative juxtamembrane cleavage site suggests the evolutionary conservation of both membrane-bound and processed CX3C forms.
Journal ArticleDOI

Activation of the Rap1 guanine nucleotide exchange gene, CalDAG-GEF I, in BXH-2 murine myeloid leukemia.

TL;DR: The results suggest that Rap1-GTP delivers signals that favor progression through the cell cycle and morphological transformation, the first evidence implicating Rap1 signaling in myeloid leukemia.